Your session is about to expire
← Back to Search
Itraconazole for Barrett's Esophagus
Study Summary
This trial will investigate if a drug can stop Barrett's esophagus from recurring after treatment, helping to prevent esophageal cancer and reduce complications.
- Barrett's Esophagitis with Dysplasia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Rewritten Criteria:
- You cannot understand and agree to participate in the study.
- You have severe heart failure.
- Your liver function tests are three times higher than normal.
- You are allergic to itraconazole.
- You are pregnant.
- Your heart's electrical system has a prolonged QTc, which can be dangerous.
- The medication you are taking interacts badly with the study drug.
- Group 1: Itraconazole in capsule form
- Group 2: Itraconazole in solution form
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential risks accompany the ingestion of Itraconazole capsules?
"With limited data substantiating its safety and efficacy, itraconazole in capsule form is assigned a score of 1 due to the Phase 1 trial status."
What is the total enrollment figure for this research project?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial is actively accruing patients; it was initially posted on September 14th 2022 and recently modified on November 1st 2022. Specifically, 10 individuals need to be recruited from one site for the study to move forward."
Have applications been opened for the current trial?
"Affirmative. Clinicaltrials.gov indicates that this research project, which was originally published on September 14th 2022 and last amended November 1st 2022, is actively looking for 10 individuals from one medical centre."
Share this study with friends
Copy Link
Messenger